Nexstim Plc Publishes 2020 Annual Report

Udgivet den 05-03-2021  |  kl. 07:00  |  

Company announcement, Helsinki, 5 March 2021 at 09.00 am (EET)

Nexstim Plc Publishes 2020 Annual Report

Nexstim Plc (NXTMH:HEX, NXTMS:STO) (Nexstim or Company) announces  the publication of its 2020 Annual Report. These documents are available on the Investor Relations section of the Company's website at nexstim.com/investors/financial-reports-and-presentations.

The Annual Report includes the Report of the Board of Directors, the Financial Statements and Consolidated Financial Statements and the Auditor's Report. A copy of the Annual Report is attached to this announcement.

NEXSTIM PLC

Mikko Karvinen, CEO

Further information is available on the website www.nexstim.com, or by contacting:

Mikko Karvinen, CEO
+358 50 326 4101
mikko.karvinen@nexstim.com


Erik Penser Bank AB (Certified Adviser
)                          
 +46 8 463 83 00
certifiedadviser@penser.se

About Nexstim Plc

Nexstim is a Finnish, globally operating medical technology company. Our mission is to enable personalized and effective therapies and diagnostics for challenging brain diseases and disorders.

Nexstim has developed a world-leading non-invasive brain stimulation technology called SmartFocus®. It is a navigated transcranial magnetic stimulation (nTMS) technology with highly sophisticated 3D navigation providing accurate and personalized targeting of the TMS to the specific area of the brain.

SmartFocus® technology is used in Nexstim's proprietary Navigated Brain Therapy (NBT®) system, which is FDA cleared for marketing and commercial distribution for the treatment of major depressive disorder (MDD) in the United States. In Europe, the NBT® system is CE marked for the treatment of major depression and chronic neuropathic pain.

In addition, Nexstim is commercializing its SmartFocus® based Navigated Brain Stimulation (NBS) system for diagnostic applications. The NBS system is the only FDA cleared and CE marked navigated TMS system for pre-surgical mapping of the speech and motor cortices of the brain. Nexstim shares are listed on the Nasdaq First North Growth Market Finland and Nasdaq First North Growth Market Sweden.

For more information please visit www.nexstim.com

 

Attachments

Nexstim Plc_Company Announcement_Annual Report 2020_EN Nexstim_AR20_BOOK_English_WEB

\Hugin

Udgivet af: NPinvestordk

Seneste nyheder

06:34 Carlsberg får skåret kursmålet med knap 5 pct. hos Goldman Sachs
06:34 Mærsk kan se positive takter hos de asiatiske konkurrenter fredag
06:34 Ennogie realiserer største ordreoptag i over et år
06:32 Asien: Investorerne sikrer de seneste dages gevinster inden amerikansk jobrapport
06:32 Valuta: Politiske valg og kommende økonomiske data giver sidelæns handel
06:32 USA/T-bond: Kun marginale udsving op til fredagens vigitge jobtal
06:32 USA/lukning: Marginale ændringer i futuresmarkedet inden jobrapport
06:30 Kalender med link - fredag den 5. juli
17:53 Ringkjøbing Landbobank får flere påbud efter tilsynsbesøg
17:49 Europa/aktier: Stigninger på britisk valgdag, men mest til tyske Continental
17:31 Fransk højreparti er langt fra flertal i meningsmålinger
17:15 Nvidia ses sælge for gigantisk milliardbeløb i Kina i år trods amerikanske restriktioner
17:05 Torsdagens aktier: Zealand igen i rekord i plusmarked med usikkerhed under overfladen
17:01 Torsdagens obligationer: Renten stod tæt på stille på fridag i USA og før jobrapport
16:32 Erhvervsorganisation frygter fiasko i historisk udbud for havvindmøller
16:02 Mærsk kan atter se fragtraterne stige: Vigtigt rateindeks er næsten firedoblet på et år
16:01 Noble/Sadif Investment: Hæver til "stærkt køb" fra "hold"
15:24 Norwegians børsværdi skrumper mere end 1,3 mia. kr. efter nedjustering
15:08 ECB's cheføkonom lufter bekymringer over høj inflation skabt inden for EU
14:59 Power tjener millioner igen - men omsætningen er faldet